Poland· PL-100478668
Tolutris
A telmisartan, amlodipin und hydrochlorothiazid product containing telmisartanum + amlodipini besilas + hydrochlorothiazidum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Telmisartan, amlodipin und hydrochlorothiazid is registered in 2 of 19 countries.
Countries holding a registration under ATC C09DX08 (telmisartan, amlodipin und hydrochlorothiazid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Telmisartan, amlodipin und hydrochlorothiazid · ATC C09DX08
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Telmisartanum + Amlodipini besilas + Hydrochlorothiazidum
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Poland (PL)
- ATC code
- C09DX08
- ATC class
- Telmisartan, Amlodipin und Hydrochlorothiazid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
1 priced- gtin0383898976423428 szt.PLN 19.29
- gtin03838989764371
- gtin03838989764043
- gtin03838989764197
- gtin03838989764159
- gtin03838989764548
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Telmisartan, amlodipin und hydrochlorothiazid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Толутрис
- Czechia · Tolvecamo
- Estonia · Tolutris
- Croatia · Tolutris
- Hungary · Tolvecamo
- Lithuania · Tolvecom
- Latvia · Tolutris
- Portugal · Tolutris
- Slovenia · Tolvecom
- Slovakia · Tolvecamo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc82f6bb-7fa6-4c2f-99aa-5725acd0100b GET /v1/drugs/cc82f6bb-7fa6-4c2f-99aa-5725acd0100b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "40 mg + 5 mg + 12,5 mg",
"packaging": "03838989764043 ¦ Rp ¦ 153772\n28 tabl. w blistrze\n03838989764197 ¦ Rp ¦ 153773\n84 tabl. w blistrze\n03838989764159 ¦ Rp ¦ 153774\n56 tabl. w blistrze\n03838989764234 ¦ Rp ¦ 153775\n28 tabl. w blistrze kalendarzowym\n03838989764548 ¦ Rp ¦ 153776\n84 tabl. w blistrze kalendarzowym\n03838989764371 ¦ Rp ¦ 153777\n56 tabl. w blistrze kalendarzowym",
"substance": "Telmisartanum 40 mg + Amlodipini besilas 5 mg + Hydrochlorothiazidum 12.5 mg",
"common_name": "Telmisartanum + Amlodipini besilas + Hydrochlorothiazidum",
"pl_product_id": "100478668",
"pozwolenie_nr": "28301",
"auth_procedure": "DCP",
"authorisation_validity": "2029-03-11"
}See everything about telmisartan, amlodipin und hydrochlorothiazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.